S
Sensei Biotherapeutics, Inc. (SNSE)
NCM – Real Time Price. Currency in USD
21.00
+0.27 (1.30%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
21.00
+0.27 (1.30%)
At close: May 12, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $10.6M significantly exceed its total debt $2.0M, ensuring strong financial flexibility
Total current assets $25.8M exceed Total current liabilities $4.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-808.5x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$3.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 5.81 | 6.05 | 10 | |
| Quick ratio | 5.81 | 5.63 | 10 | |
| Debt to Equity | 0.09 | 0.30 | 9.0 | |
| Debt to Assets | 0.07 | 1.04 | 9.0 | |
| Interest coverage | -808.50 | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -2M | -571K | -551K | -139K | -240K |
| Operating Income | -49M | -37M | -32M | -22M | -25M |
| Net Income | -49M | -34M | -30M | -21M | -24M |
| EBITDA | -47M | -36M | -31M | -22M | -24M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 88.52 | 5.5 |
| Next quarter | N/A | 82.86 | 5.5 |
| Current year | N/A | 83.43 | 5.5 |
| Next year | N/A | -36.1 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 7.44 | 7.42 | 39.48 | 7.5 |
| Y/Y | 999 | 37.01 | 37.59 | 34.44 | 10 |
| 3y average | 999 | 23.82 | 18.25 | 19.54 | 9.5 |
| 5y average | 999 | -8.71 | 25.07 | -6.78 | 5.5 |
| Weighted average score | 8.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |